Within-patient evolution to piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS 26 -mediated amplification of bla TEM-1B (2020)

First Author: Hubbard A

Attributed to: Drivers of Resistance in Uganda and Malawi: The DRUM Consortium funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2020.02.28.969360

Publication URI: http://dx.doi.org/10.1101/2020.02.28.969360

Type: Preprint